3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
11
Stomach Neoplasms
5
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Ovarian Neoplasms
2
Gastric Adenocarcinoma
2
Cholangiocarcinoma
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Gastric Cancer
2
Adenocarcinoma
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Radioactive Iodine-refractory Differentiated Thyroid Cancer
1
Osteosarcoma
1
Neuroblastoma
1
Malignant Neoplasms of Digestive Organs
1
Liver Neoplasms
1
Gestational Trophoblastic Disease
1
Gastrointestinal Stromal Tumors
1
Fludzoparib" and Anti-angiogenic
1
Colonic Neoplasms
1
Cirrhosis, Familial, with Pulmonary Hypertension
1
Advanced Primary Liver Cancer
1
Advanced Biliary Tract Carcinoma
1
Adebrelimab
1
Interventions
Specimen Handling
9
Magnetic Resonance Spectroscopy
6
Biopsy
6
pembrolizumab
3
X-Rays
3
Nivolumab
3
olaparib
2
durvalumab
2
ceralasertib
2
Paclitaxel
2
Immunoglobulin G
2
Carboplatin
2
trastuzumab deruxtecan
1
sargramostim
1
ribociclib
1
pelcitoclax
1
cobimetinib
1
cediranib
1
capivasertib
1
cabozantinib
1
atezolizumab
1
Tissue Banks
1
Taxes
1
TIC10 compound
1
Radiation
1
Phantoms, Imaging
1
Minimally Invasive Surgical Procedures
1
Ipilimumab
1
Indocyanine Green
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
apatinib
×
1 year
×
Clear all
No trials found.